Risk factors for treatment-related sensorineural hearing loss and hearing aid use in medulloblastoma patients: an observational cohort study
Young age and cochlear EQD2 D<sub>mean</sub> ≥40 Gy are significant risk factors for the incidence, degree, and time-to-event of SNHL as well as for IHA in medulloblastoma patients.
Authors
- Julian Roers
- Christopher Kittel
- Fabian M. Troschel (ORCID: https://orcid.org/0000-0001-5066-6650)
- David Rene Steike (ORCID: https://orcid.org/0009-0004-7576-2373)
- Ross Parfitt (ORCID: https://orcid.org/0000-0003-2334-0211)
- Katrin Neumann (ORCID: https://orcid.org/0000-0002-3975-0736)
- Jan Siats
- Sergiu Scobioala (ORCID: https://orcid.org/0000-0001-9622-3169)
- Antoinette am Zehnhoff‐Dinnesen (ORCID: https://orcid.org/0000-0002-6146-1500)
- Amélie E. Hesping
- Hans Theodor Eich
Institutions
- University Hospital Münster (DE)
Publication Details
- Journal
- Strahlentherapie und Onkologie
- Published
- 2024-10-25
- DOI
- https://doi.org/10.1007/s00066-024-02308-5
- Citations
- 2
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.88